14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.071 22 days ( 22.73 % )
Last Price $2.21 -5.15 %
High/ Low $2.15 - $2.33 12.33%
Chg 7 Days 1.84 % $2.17 $2.21
Chg 30 Days -23.00 % $2.87 $2.21
Chg 12 mos -6.75 % $2.37 $2.21
Trend - 3 mos -27.90 % Width: 45.00 %
Trend - 12 mos 27.53 % Width: 268.13 %
Pred. range - 3 mos $1.41 - $2.04 -36.19 % - -7.47 %
Pred. range - 12 mos $2.75 - $10.12 24.33 % - 357.70 %
Short MA avg 3 mos Sell May 06, 2024 - 2 days
Long MA avg 3 mos Sell Mar 25, 2024 - 31 days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Apr 02, 2024 - 26 days
Long MA avg 12 mos Sell Jan 24, 2024 - 73 days
Short/Long MA avg 12 mos Sell Feb 07, 2024 - 63 days
Pivot Short Sell Apr 25, 2024 - 9 days
Bollinger Buy Aug 17, 2023 - 182 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Immix Biopharma, Inc.

Immix Biopharma. Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the tr... IMMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT